An Open Label Pilot Trial of Oral Vancomycin in Primary Sclerosing Cholangitis - Results of the VIP Trial

被引：0
|
作者：
Pratt, Daniel
Agarwal, Sheela
Saini, Sanjay
Misdraji, Joseph
Korzenik, Joshua R.
机构：
来源：
GASTROENTEROLOGY | 2011年 / 140卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S907 / S907
页数：1
相关论文
共 50 条
  • [41] The Effectiveness of Oral Vancomycin on Inflammatory Bowel Disease in Patients With Primary Sclerosing Cholangitis: A Systematic Review
    Arbabzada, Naik
    Dennett, Liz
    Meng, Guanmin
    Peerani, Farhad
    INFLAMMATORY BOWEL DISEASES, 2024,
  • [42] Long-term treatment of primary sclerosing cholangitis in children with oral vancomycin: An immunomodulating antibiotic
    Davies, Yinka K.
    Cox, Kathleen M.
    Abdullah, Bisher A.
    Safta, Anca
    Terry, Annie B.
    Cox, Kenneth L.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2008, 47 (01): : 61 - 67
  • [43] Vascular adhesion protein-1 blockade in primary sclerosing cholangitis: Open-label, multicenter, single-arm, phase II trial
    Hirschfield, Gideon M.
    Arndtz, Katherine
    Kirkham, Amanda
    Chen, Yung-Yi
    Fox, Richard
    Rowe, Anna
    Douglas-Pugh, Jessica
    Thorburn, Douglas
    Barnes, Eleanor
    Aithal, Guruprasad P.
    Hull, Diana
    Bhandal, Khushpreet
    Olsen, Kathryn
    Woodward, Paul
    Lax, Sian
    Newsome, Philip
    Smith, David J.
    Kallio, Antero
    Adams, David H.
    Homer, Victoria
    Weston, Chris J.
    HEPATOLOGY COMMUNICATIONS, 2024, 8 (05)
  • [44] Successful Treatment of Primary Sclerosing Cholangitis With Oral Vancomycin for Over 7 Years: A Case Report
    Mahajan, Ashley
    Sharpio, Arielle
    Mahajan, Lori
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S779 - S779
  • [45] How frequent are vancomycin-resistant enterococci in patients with primary sclerosing cholangitis and ulcerative colitis treated with oral vancomycin?
    Shah, Ayesha
    Pakneeshan, Sahar
    Jones, Michael P.
    Koloski, Natasha
    Callaghan, Gavin
    Morrison, Mark
    Holtmann, Gerald
    INDIAN JOURNAL OF GASTROENTEROLOGY, 2022, 41 (05) : 519 - 524
  • [46] How frequent are vancomycin-resistant enterococci in patients with primary sclerosing cholangitis and ulcerative colitis treated with oral vancomycin?
    Ayesha Shah
    Sahar Pakneeshan
    Michael P Jones
    Natasha Koloski
    Gavin Callaghan
    Mark Morrison
    Gerald Holtmann
    Indian Journal of Gastroenterology, 2022, 41 : 519 - 524
  • [47] Editorial: vancomycin - a promising option for the treatment of primary sclerosing cholangitis?
    Chapman, R. W.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (09) : 1321 - 1322
  • [48] An open label phase II pilot trial of tacrolimus for primary biliary cirrhosis (PBC)
    Luketic, VA
    Sargeant, C
    Stravitz, T
    Shiffman, ML
    Sterling, RK
    Contos, MJ
    Mills, AS
    Sanyal, A
    HEPATOLOGY, 2005, 42 (04) : 464A - 465A
  • [49] A DOUBLE-BLIND CONTROLLED TRIAL OF ORAL-PULSE METHOTREXATE THERAPY IN THE TREATMENT OF PRIMARY SCLEROSING CHOLANGITIS
    KNOX, TA
    KAPLAN, MM
    GASTROENTEROLOGY, 1994, 106 (02) : 494 - 499
  • [50] Reply: Insurance should cover vancomycin for primary sclerosing cholangitis
    Bowlus, Christopher L.
    Arrive, Lionel
    Bergquist, Annika
    Deneau, Mark
    Forman, Lisa
    Ilyas, Sumera I.
    Lunsford, Keri E.
    Martinez, Mercedes
    Sapisochin, Gonzalo
    Shroff, Rachna
    Tabibian, James H.
    Assis, David N.
    HEPATOLOGY, 2023, 77 (06) : E176 - E177
12345